Clinical Trial Update: Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating short-duration therapy for acute hepatitis C genotypes 1 or 4; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Snippet

Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | Conditions: Acute Hepatitis C, HIV | Phase 2 | Status: COMPLETED | Results posted: 2020-01-29